Insights into the molecular mechanism of chronic fibrosis: the role of connective tissue growth factor in scleroderma
- PMID: 14962082
- DOI: 10.1046/j.0022-202X.2003.22133.x
Insights into the molecular mechanism of chronic fibrosis: the role of connective tissue growth factor in scleroderma
Abstract
Connective tissue growth factor (CCN2), a member of the CCN family of proteins, is a cysteine-rich matricellular protein. Connective tissue growth factor is not normally expressed in dermal fibroblasts unless induced. The most potent inducer of connective tissue growth factor thus far identified is transforming growth factor beta. Connective tissue growth factor, however, is constitutively overexpressed by fibroblasts present in skin fibrotic lesions, including scleroderma. The overexpression of connective tissue growth factor present in fibrotic lesions contributes to the phenotype of scleroderma in that connective tissue growth factor promotes matrix deposition, and fibroblast adhesion and proliferation. In animal models, whereas either transforming growth factor beta or connective tissue growth factor alone produce only a transient fibrotic response, connective tissue growth factor and transforming growth factor beta act together to promote sustained fibrosis. Thus the constitutive overexpression of connective tissue growth factor by fibroblasts present in fibrotic lesions would be expected to contribute directly to chronic, persistent fibrosis. This review discusses recent information regarding insights into connective tissue growth factor biology and, using scleroderma as a model system, the part connective tissue growth factor might play in fibrotic disease.
Similar articles
-
Transcriptional profiling of the scleroderma fibroblast reveals a potential role for connective tissue growth factor (CTGF) in pathological fibrosis.Keio J Med. 2004 Jun;53(2):74-7. doi: 10.2302/kjm.53.74. Keio J Med. 2004. PMID: 15247510 Review.
-
Constitutive connective tissue growth factor expression in scleroderma fibroblasts is dependent on Sp1.J Biol Chem. 2003 Oct 24;278(43):41728-33. doi: 10.1074/jbc.M305019200. Epub 2003 Jul 29. J Biol Chem. 2003. PMID: 12888575
-
Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis.Exp Cell Res. 2000 Aug 25;259(1):213-24. doi: 10.1006/excr.2000.4972. Exp Cell Res. 2000. PMID: 10942593
-
The control of ccn2 (ctgf) gene expression in normal and scleroderma fibroblasts.Mol Pathol. 2001 Jun;54(3):180-3. doi: 10.1136/mp.54.3.180. Mol Pathol. 2001. PMID: 11376132 Free PMC article.
-
_targeting the TGFbeta, endothelin-1 and CCN2 axis to combat fibrosis in scleroderma.Cell Signal. 2008 Aug;20(8):1409-14. doi: 10.1016/j.cellsig.2008.01.006. Epub 2008 Jan 19. Cell Signal. 2008. PMID: 18296024 Review.
Cited by
-
Vesicoureteral reflux and the extracellular matrix connection.Pediatr Nephrol. 2017 Apr;32(4):565-576. doi: 10.1007/s00467-016-3386-5. Epub 2016 May 2. Pediatr Nephrol. 2017. PMID: 27139901 Free PMC article. Review.
-
Quantitative relationships between SMAD dynamics and _target gene activation kinetics in single live cells.Sci Rep. 2019 Mar 29;9(1):5372. doi: 10.1038/s41598-019-41870-2. Sci Rep. 2019. PMID: 30926874 Free PMC article.
-
Surface morphology and mechanical properties of fibroblasts from scleroderma patients.J Cell Mol Med. 2009 Aug;13(8B):1644-1652. doi: 10.1111/j.1582-4934.2008.00401.x. J Cell Mol Med. 2009. PMID: 18624756 Free PMC article.
-
Connective Tissue Growth Factor Domain 4 Amplifies Fibrotic Kidney Disease through Activation of LDL Receptor-Related Protein 6.J Am Soc Nephrol. 2017 Jun;28(6):1769-1782. doi: 10.1681/ASN.2016080826. Epub 2017 Jan 27. J Am Soc Nephrol. 2017. PMID: 28130402 Free PMC article.
-
MicroRNA-26b inhibits metastasis of osteosarcoma via _targeting CTGF and Smad1.Tumour Biol. 2015 Aug;36(8):6201-9. doi: 10.1007/s13277-015-3305-6. Epub 2015 Mar 12. Tumour Biol. 2015. PMID: 25761878
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous